Found: 22
Select item for more details and to access through your institution.
Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center.
- Published in:
- Integrative Cancer Therapies, 2017, v. 16, n. 1, p. 96, doi. 10.1177/1534735416660384
- By:
- Publication type:
- Article
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e509, doi. 10.1093/cid/ciab1059
- By:
- Publication type:
- Article
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
- Published in:
- Nature, 2006, v. 439, n. 7074, p. 353, doi. 10.1038/nature04296
- By:
- Publication type:
- Article
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
- Published in:
- PLoS ONE, 2021, v. 16, n. 11, p. 1, doi. 10.1371/journal.pone.0256615
- By:
- Publication type:
- Article
Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterations.
- Published in:
- Journal of Surgical Oncology, 2009, v. 100, n. 6, p. 511, doi. 10.1002/jso.21372
- By:
- Publication type:
- Article
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 3, p. 765, doi. 10.1245/s10434-019-08039-7
- By:
- Publication type:
- Article
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 195, doi. 10.1007/s10549-020-05922-w
- By:
- Publication type:
- Article
Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0294448
- By:
- Publication type:
- Article
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53695-0
- By:
- Publication type:
- Article
BAD-mediated apoptotic pathway is associated with human cancer development.
- Published in:
- International Journal of Molecular Medicine, 2015, v. 35, n. 4, p. 1081, doi. 10.3892/ijmm.2015.2091
- By:
- Publication type:
- Article
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing.
- Published in:
- Journal of Ovarian Research, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13048-021-00809-w
- By:
- Publication type:
- Article
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin.
- Published in:
- Journal of Gynecologic Oncology, 2012, v. 23, n. 1, p. 35, doi. 10.3802/jgo.2012.23.1.35
- By:
- Publication type:
- Article
Gene Expression Patterns That Characterize Advanced Stage Serous Ovarian Cancers.
- Published in:
- Reproductive Sciences, 2004, v. 11, n. 1, p. 51, doi. 10.1016/j.jsgi.2003.07.004
- By:
- Publication type:
- Article
Matrix Metalloproteinase-1 Gene Promoter Polymorphism and Risk of Ovarian Cancer.
- Published in:
- Reproductive Sciences, 2003, v. 10, n. 6, p. 381, doi. 10.1016/S1071-5576(03)00141-2
- By:
- Publication type:
- Article
Matrix Metalloproteinase-1 Gene Promoter Polymorphism and Risk of Ovarian Cancer.
- Published in:
- Reproductive Sciences, 2003, v. 10, n. 6, p. 381, doi. 10.1016/S1071-55760300141-2
- By:
- Publication type:
- Article
Aberrant Splicing of the TSG101 Tumor Suppressor Gene in Human Breast and Ovarian Cancers.
- Published in:
- Reproductive Sciences, 1998, v. 5, n. 5, p. 281, doi. 10.1177/107155769800500510
- By:
- Publication type:
- Article
Dideoxy fingerprinting assay for BRCA1 mutation analysis.
- Published in:
- Molecular Carcinogenesis, 1997, v. 19, n. 3, p. 176, doi. 10.1002/(SICI)1098-2744(199707)19:3<176::AID-MC5>3.0.CO;2-C
- By:
- Publication type:
- Article
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.
- Published in:
- Molecular Carcinogenesis, 1996, v. 17, n. 3, p. 160, doi. 10.1002/(SICI)1098-2744(199611)17:3<160::AID-MC8>3.0.CO;2-J
- By:
- Publication type:
- Article
Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1996, v. 88, n. 8, p. 552, doi. 10.1093/jnci/88.8.552
- By:
- Publication type:
- Article
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.
- Published in:
- Oncology Letters, 2016, v. 11, n. 1, p. 323, doi. 10.3892/ol.2015.3883
- By:
- Publication type:
- Article
Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 3, p. 399, doi. 10.3892/mco.2016.725
- By:
- Publication type:
- Article
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 3, p. 612, doi. 10.1002/ijc.29799
- By:
- Publication type:
- Article